Sanofi to sell Ankleshwar site to Zentiva

11 Sep 2019 Evaluate

Sanofi’s Board of Directors has approved a transaction for the slump sale and transfer of its manufacturing facility at Ankleshwar in Gujarat to Zentiva and its legal entity in India, Zentiva for a consideration of Rs 261.7 crore, subject to customary working capital adjustments. This transaction is subject to shareholders’ approval and the completion of certain conditions as defined under the Business Transfer Agreement (BTA).

The Ankleshwar site is Sanofi India’s oldest manufacturing facility where brands like Combiflam, Allegra and Amaryl are made. The production of these iconic brands will now be moved to the company’s Goa site and external manufacturing sites as well.

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health.

Sanofi India Share Price

4334.40 -37.30 (-0.85%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×